NEW YORK, March 30, 2016 /PRNewswire/ -- The purpose of this report is to cover the definition, description, and forecast of Global Extracorporeal Membrane Oxygenation (ECMO) System market. It involves deep dive analysis of market segmentation which comprises of submarkets, modality and application. The report also offers strategic analysis of key players in the market. In this report, the Extracorporeal Membrane Oxygenation (ECMO) System market is segmented on the basis of its modality and application. In terms of modality, the market is segmented into Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R).
This market has been segmented by application, which includes Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment was the largest application of the global Extracorporeal Membrane Oxygenation (ECMO) System market in 2014.
Globally, North America contributed to the largest Extracorporeal Membrane Oxygenation (ECMO) System market in 2014. The large share is attributed to rise in the increasing number of patients suffering from respiratory failure and cardiopulmonary disease, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), increasing adoption rate of ECMO machine in hospitals, technological advancements in ECMO system, success rate of ECMO and government initiatives and growing awareness towards ECMO. All these factors would help improve the demand of ECMO machines, which are used on a small scale in hospitals currently.
Furthermore, increasing number of patients suffering from respiratory failure and cardiopulmonary disease are other growth factors. With the rising number of cases globally, there is a boost in the growth of extra corporeal membrane oxygenators market. Respiratory failure may affect the muscles, nerves, bones, or tissues that support breathing, or they may affect the lungs directly. Over 3 million Canadians of all ages have a serious respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), cystic fibrosis, and respiratory distress syndrome. More than 5 million patients are admitted annually to ICUs in the U.S. In 2010, cardiovascular, lung, and blood diseases accounted for 1,017,000 deaths and 41 percent of all deaths in the U.S. However, cost of high end equipment, presence of conventional techniques, risk of complications, renal failure associated with ECMO are some of the restraints for the Extracorporeal Membrane Oxygenation (ECMO) System market.
The report also provides a detailed competitive landscaping of companies operating in this market. It also offers segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of major companies. The main companies operating in this market are MAQUET Holding B.V. & CO. KG. (Germany), SORIN Group (Italy), MEDTRONIC (Republic of Ireland), NIPRO Medical Corporation (U.S.), Terumo Medical Corporation (Japan), MicroPort Scientific Corporation (China), Medos Medizintechnik AG (Germany).
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Also, the report covers basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the Extracorporeal Membrane Oxygenation (ECMO) System market.
The report offers detailed information on new entrants/smaller firms to gauge the pulse of the market, which in turn helps garner the market share. The firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.
The report provides insights on the following pointers:
- Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the market.
- Market Development: Offers comprehensive information about lucrative emerging markets. Analysis of market across various regions; distribution channels, clientele base and pricing policies involved vis-à-vis geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions. Detailed description regarding the related and unrelated diversification pertaining to the market.
- Competitive Assessment: An in-depth assessment of market shares and company share analyses of the key players projected till 2020. Business strategies and manufacturing capabilities of leading players are also provided.
Read the full report: http://www.reportlinker.com/p03506431-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/extracorporeal-membrane-oxygenation-systems-market-by-modality-veno--venous-arterio-venous-by-application-by-geography---global-forecast-to-2020-300243662.html